PROMOTING SCIENCE AND TECHNOLOGY BETWEEN INDIA AND THE U.S.

Joel Schneider

NIH Center for Cancer Research Joel Schneider.jpg

Research Area

Biochemistry, Biomedical Engineering, Molecular Biology

Institution

National Cancer Institute (NCI) at National Institute of Health (NIH)

The Schneider group designs and characterizes novel materials for use in tissue regenerative therapy, parenteral delivery of therapeutics, delivery of cells, and antibacterial therapy. We are particularly interested in peptide and protein-based hydrogel materials formed by self-assembly mechanisms. Our work spans molecular conception, materials synthesis, nano- and bulk mechanical materials characterization, cell-material interactions, biocompatibility, and assessment of performance efficacy. Our basic research establishes how material composition and structure influences material function, and lays the foundation to ultimately translate materials to the clinic.

Sign Up to Receive Our Newsletter